Skip to content

Clinical trials

Completed Hematologic Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Status: Completed Country / region: South Korea Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20112
20121
20132
20143
20151
20171
20184
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
BioMarin Pharmaceutical2
Genzyme, a Sanofi Company2
Il-Yang Pharm. Co., Ltd.2
Amgen1
Pfizer1
Seagen Inc.1
Seoul National University Hospital1
Sierra Oncology LLC - a GSK company1
Sunesis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases18
Bone Marrow Diseases7
Leukemia7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Leukemia, Myeloid5
Blood Coagulation Disorders4
Blood Coagulation Disorders, Inherited4
Coagulation Protein Disorders4
Genetic Diseases, Inborn4
Hemophilia A4

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.